GIP
ADPT icon

Granite Investment Partners’s Adaptive Biotechnologies ADPT Stock Holding History

Granite Investment Partners’s Portfolio ADPT Stock Details ADPT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$6.94M Buy
+500,061
New +$7.97M 0.43% 86
2025
Q4 		– Sell
-10,070
Closed -$151K – 245
2025
Q3 		$151K Buy
10,070
+64
+0.6% +$780 0.01% 234
2025
Q2 		$117K Sell
10,006
-1,443
-13% -$13.1K 0.01% 241
2025
Q1 		$85.1K Buy
+11,449
New +$88K ﹤0.01% 246

Other funds holding ADPT

Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Westfield Capital Management
Westfield Capital Management Boston, Massachusetts $23.8B AUM 49.45% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Lord, Abbett & Co
Lord, Abbett & Co Jersey City, New Jersey $30.6B AUM 57.44% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Granite Investment Partners's ADPT Position: Q1 2026 in Review

Granite Investment Partners opened a new position in Adaptive Biotechnologies (ADPT) in Q1 2026: 500,061 shares worth $6.94M. The stake represents 0.43% of the portfolio and ranks #86 among its holdings. This is a return to the name: Granite Investment Partners previously reported a position in ADPT as recently as Q3 2025.

Granite Investment Partners first reported a position in ADPT in Q1 2025 and has held it in 4 quarters since. 295 funds tracked by Wall St. Rank hold ADPT as of Q1 2026.

  • Granite Investment Partners held 500,061 shares of Adaptive Biotechnologies worth $6.94M as of Q1 2026.
  • Adaptive Biotechnologies was a new Granite Investment Partners position in Q1 2026.
  • Adaptive Biotechnologies made up 0.43% of Granite Investment Partners's portfolio in Q1 2026, its #86 holding.
  • Granite Investment Partners first reported a position in Adaptive Biotechnologies in Q1 2025 and has held it in 4 quarters since.
  • 295 funds tracked by Wall St. Rank held Adaptive Biotechnologies as of Q1 2026.

Based on Granite Investment Partners's 13F filing for Q1 2026, filed 30 Apr 2026.